$KERX Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in KERYX BIOPHARMACEUTICALS INC.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview

Overview of all insider trading transactions in KERYX BIOPHARMACEUTICALS INC. Get notifications about new insider transactions in KERYX BIOPHARMACEUTICALS INC for free.

Page: 1 2 3 4 5 ... 5 next >

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Dec 13 2018	KERX	KERYX BIOPHARMACEU ...	ROGERS MICHAEL W	Director	Option Exercise	D	0.00	140,000	0	0
Dec 13 2018	KERX	KERYX BIOPHARMACEU ...	ROGERS MICHAEL W	Director	Sell	D	0.00	30,000	0	0	30 K to 0 (-100.00 %)
Dec 13 2018	KERX	KERYX BIOPHARMACEU ...	Enyedy Mark J	Director	Option Exercise	D	0.00	80,000	0	0
Dec 13 2018	KERX	KERYX BIOPHARMACEU ...	Enyedy Mark J	Director	Sell	D	0.00	10,000	0	0	10 K to 0 (-100.00 %)
Dec 13 2018	KERX	KERYX BIOPHARMACEU ...	Holmes Scott A	Chief Financial Off ...	Option Exercise	D	0.00	902,500	0	0
Dec 13 2018	KERX	KERYX BIOPHARMACEU ...	Holmes Scott A	Chief Financial Off ...	Sell	D	0.00	162,956	0	0	163 K to 0 (-100.00 %)
Dec 13 2018	KERX	KERYX BIOPHARMACEU ...	Morrison Jodie Pope	Interim CEO	Option Exercise	D	0.00	110,000	0	0
Dec 13 2018	KERX	KERYX BIOPHARMACEU ...	Morrison Jodie Pope	Interim CEO	Sell	D	0.00	120,000	0	0	120 K to 0 (-100.00 %)
Dec 13 2018	KERX	KERYX BIOPHARMACEU ...	Regan Daniel Paul	Director	Option Exercise	D	0.00	200,000	0	0
Dec 13 2018	KERX	KERYX BIOPHARMACEU ...	Regan Daniel Paul	Director	Sell	D	0.00	60,000	0	0	60 K to 0 (-100.00 %)
Dec 13 2018	KERX	KERYX BIOPHARMACEU ...	Heffernan Michael Thomas	Director	Option Exercise	D	0.00	110,000	0	0
Dec 13 2018	KERX	KERYX BIOPHARMACEU ...	Heffernan Michael Thomas	Director	Sell	D	0.00	20,000	0	0	20 K to 0 (-100.00 %)
Dec 13 2018	KERX	KERYX BIOPHARMACEU ...	GILMAN STEVEN C	Director	Option Exercise	D	0.00	140,000	0	0
Dec 13 2018	KERX	KERYX BIOPHARMACEU ...	GILMAN STEVEN C	Director	Sell	D	0.00	27,333	0	0	27.3 K to 0 (-100.00 %)
Dec 13 2018	KERX	KERYX BIOPHARMACEU ...	Neylan John F.	Chief Medical Offic ...	Option Exercise	D	0.00	772,500	0	0
Dec 13 2018	KERX	KERYX BIOPHARMACEU ...	Neylan John F.	Chief Medical Offic ...	Sell	D	0.00	148,279	0	0	148.3 K to 0 (-100.00 %)
Dec 13 2018	KERX	KERYX BIOPHARMACEU ...	Cameron Kevin J	Director	Option Exercise	D	0.00	290,000	0	0
Dec 13 2018	KERX	KERYX BIOPHARMACEU ...	Cameron Kevin J	Director	Sell	D	0.00	186,666	0	0	186.7 K to 0 (-100.00 %)
Dec 13 2018	KERX	KERYX BIOPHARMACEU ...	Carberry Christine A.	Chief Operating Off ...	Option Exercise	D	0.00	422,500	0	0
Dec 13 2018	KERX	KERYX BIOPHARMACEU ...	Carberry Christine A.	Chief Operating Off ...	Sell	D	0.00	100,646	0	0	100.6 K to 0 (-100.00 %)
Dec 13 2018	KERX	KERYX BIOPHARMACEU ...	Carberry Christine A.	Chief Operating Off ...	Sell	S	3.22	10,469	33,710	100,646	111.1 K to 100.6 K (-9.42 %)
Dec 13 2018	KERX	KERYX BIOPHARMACEU ...	BAUPOST GROUP LLC/MA	Director	Sell	D	0.00	65,374,013	0	0	65.4 M to 0 (-100.00 %)
Dec 13 2018	KERX	KERYX BIOPHARMACEU ...	BAUPOST GROUP LLC/MA	Director	Grant	A	0.00	4,000,000	0	65,374,013	61.4 M to 65.4 M (+6.52 %)
Dec 13 2018	KERX	KERYX BIOPHARMACEU ...	BAUPOST GROUP LLC/MA	Director	Grant	A	4.63	35,582,335	164,746,211	61,374,013	25.8 M to 61.4 M (+137.96 %)
Nov 16 2018	KERX	KERYX BIOPHARMACEU ...	Neylan John F.	Chief Medical Offic ...	Sell	S	2.77	1,156	3,202	148,279	149.4 K to 148.3 K (-0.77 %)
Nov 16 2018	KERX	KERYX BIOPHARMACEU ...	Holmes Scott A	Chief Financial Off ...	Sell	S	2.77	1,155	3,199	162,956	164.1 K to 163 K (-0.70 %)
Oct 30 2018	KERX	KERYX BIOPHARMACEU ...	Neylan John F.	Chief Medical Offic ...	Sell	S	3.07	1,253	3,847	149,435	150.7 K to 149.4 K (-0.83 %)
Oct 30 2018	KERX	KERYX BIOPHARMACEU ...	Holmes Scott A	Chief Financial Off ...	Sell	S	3.07	1,254	3,850	164,111	165.4 K to 164.1 K (-0.76 %)
Oct 22 2018	KERX	KERYX BIOPHARMACEU ...	Carberry Christine A.	Chief Operating Off ...	Sell	S	3.29	2,040	6,712	111,115	113.2 K to 111.1 K (-1.80 %)
Aug 16 2018	KERX	KERYX BIOPHARMACEU ...	Holmes Scott A	Chief Financial Off ...	Sell	S	3.04	1,185	3,602	165,365	166.6 K to 165.4 K (-0.71 %)
Aug 16 2018	KERX	KERYX BIOPHARMACEU ...	Neylan John F.	Chief Medical Offic ...	Sell	S	3.04	1,186	3,605	150,688	151.9 K to 150.7 K (-0.78 %)
Jul 31 2018	KERX	KERYX BIOPHARMACEU ...	Neylan John F.	Chief Medical Offic ...	Sell	S	3.86	1,282	4,949	151,874	153.2 K to 151.9 K (-0.84 %)
Jul 31 2018	KERX	KERYX BIOPHARMACEU ...	Holmes Scott A	Chief Financial Off ...	Sell	S	3.86	2,354	9,086	166,550	168.9 K to 166.6 K (-1.39 %)
Jul 19 2018	KERX	KERYX BIOPHARMACEU ...	Carberry Christine A.	Chief Operating Off ...	Sell	S	4.49	2,021	9,074	113,155	115.2 K to 113.2 K (-1.75 %)
Jul 12 2018	KERX	KERYX BIOPHARMACEU ...	Cameron Kevin J	Director	Option Exercise	A	3.76	30,000	112,800	30,000
Jul 12 2018	KERX	KERYX BIOPHARMACEU ...	Cameron Kevin J	Director	Grant	A	0.00	10,000	0	186,666	176.7 K to 186.7 K (+5.66 %)
Jul 12 2018	KERX	KERYX BIOPHARMACEU ...	GILMAN STEVEN C	Director	Option Exercise	A	3.76	30,000	112,800	30,000
Jul 12 2018	KERX	KERYX BIOPHARMACEU ...	GILMAN STEVEN C	Director	Grant	A	0.00	10,000	0	27,333	17.3 K to 27.3 K (+57.69 %)
Jul 12 2018	KERX	KERYX BIOPHARMACEU ...	ROGERS MICHAEL W	Director	Option Exercise	A	3.76	30,000	112,800	30,000
Jul 12 2018	KERX	KERYX BIOPHARMACEU ...	ROGERS MICHAEL W	Director	Grant	A	0.00	10,000	0	30,000	20 K to 30 K (+50.00 %)
Jul 12 2018	KERX	KERYX BIOPHARMACEU ...	Enyedy Mark J	Director	Option Exercise	A	3.76	30,000	112,800	30,000
Jul 12 2018	KERX	KERYX BIOPHARMACEU ...	Enyedy Mark J	Director	Grant	A	0.00	10,000	0	10,000	0 to 10 K
Jul 12 2018	KERX	KERYX BIOPHARMACEU ...	Morrison Jodie Pope	Interim CEO	Option Exercise	A	3.76	30,000	112,800	30,000
Jul 12 2018	KERX	KERYX BIOPHARMACEU ...	Morrison Jodie Pope	Interim CEO	Grant	A	0.00	10,000	0	120,000	110 K to 120 K (+9.09 %)
Jul 12 2018	KERX	KERYX BIOPHARMACEU ...	Regan Daniel Paul	Director	Option Exercise	A	3.76	30,000	112,800	30,000
Jul 12 2018	KERX	KERYX BIOPHARMACEU ...	Regan Daniel Paul	Director	Grant	A	0.00	10,000	0	60,000	50 K to 60 K (+20.00 %)
Jul 12 2018	KERX	KERYX BIOPHARMACEU ...	Heffernan Michael Thomas	Director	Option Exercise	A	3.76	30,000	112,800	30,000
Jul 12 2018	KERX	KERYX BIOPHARMACEU ...	Heffernan Michael Thomas	Director	Grant	A	0.00	10,000	0	20,000	10 K to 20 K (+100.00 %)
Jun 19 2018	KERX	KERYX BIOPHARMACEU ...	Cameron Kevin J	Director	Sell	S	4.98	1,667	8,302	176,666	178.3 K to 176.7 K (-0.93 %)
Jun 18 2018	KERX	KERYX BIOPHARMACEU ...	Cameron Kevin J	Director	Option Exercise	M	0.48	10,000	4,800	0
Jun 18 2018	KERX	KERYX BIOPHARMACEU ...	Cameron Kevin J	Director	Buy	M	0.48	10,000	4,800	178,333	168.3 K to 178.3 K (+5.94 %)
Jun 12 2018	KERX	KERYX BIOPHARMACEU ...	GILMAN STEVEN C	Director	Sell	S	5.12	1,334	6,830	17,333	18.7 K to 17.3 K (-7.15 %)
May 31 2018	KERX	KERYX BIOPHARMACEU ...	Cameron Kevin J	Director	Sell	S	5.22	1,667	8,702	168,333	170 K to 168.3 K (-0.98 %)
May 31 2018	KERX	KERYX BIOPHARMACEU ...	GILMAN STEVEN C	Director	Sell	S	5.22	1,333	6,958	18,667	20 K to 18.7 K (-6.66 %)
May 16 2018	KERX	KERYX BIOPHARMACEU ...	Holmes Scott A	Chief Financial Off ...	Sell	S	5.69	1,158	6,589	168,904	170.1 K to 168.9 K (-0.68 %)
May 16 2018	KERX	KERYX BIOPHARMACEU ...	Neylan John F.	Chief Medical Offic ...	Sell	S	5.69	1,158	6,589	153,156	154.3 K to 153.2 K (-0.75 %)
May 16 2018	KERX	KERYX BIOPHARMACEU ...	Holmes Scott A	Chief Financial Off ...	Sell	S	5.69	1,158	6,589	168,904	170.1 K to 168.9 K (-0.68 %)
May 16 2018	KERX	KERYX BIOPHARMACEU ...	Neylan John F.	Chief Medical Offic ...	Sell	S	5.69	1,158	6,589	153,156	154.3 K to 153.2 K (-0.75 %)
May 14 2018	KERX	KERYX BIOPHARMACEU ...	Morrison Jodie Pope	Interim CEO	Grant	A	0.00	100,000	0	110,000	10 K to 110 K (+1,000.00 %)
May 14 2018	KERX	KERYX BIOPHARMACEU ...	Morrison Jodie Pope	Interim CEO	Grant	A	0.00	100,000	0	110,000	10 K to 110 K (+1,000.00 %)
May 01 2018	KERX	KERYX BIOPHARMACEU ...	Holmes Scott A	Chief Financial Off ...	Sell	S	4.67	2,407	11,241	170,062	172.5 K to 170.1 K (-1.40 %)
May 01 2018	KERX	KERYX BIOPHARMACEU ...	Neylan John F.	Chief Medical Offic ...	Sell	S	4.67	1,311	6,122	154,314	155.6 K to 154.3 K (-0.84 %)
Apr 24 2018	KERX	KERYX BIOPHARMACEU ...	Neylan John F.	Chief Medical Offic ...	Sell	S	4.59	1,111	5,099	155,625	156.7 K to 155.6 K (-0.71 %)
Apr 20 2018	KERX	KERYX BIOPHARMACEU ...	Carberry Christine A.	Chief Operating Off ...	Sell	S	4.83	2,026	9,786	115,176	117.2 K to 115.2 K (-1.73 %)
Mar 22 2018	KERX	KERYX BIOPHARMACEU ...	Madison Greg	President and CEO	Option Exercise	A	4.16	305,000	1,268,800	305,000
Mar 22 2018	KERX	KERYX BIOPHARMACEU ...	Madison Greg	President and CEO	Grant	A	0.00	152,500	0	566,586	414.1 K to 566.6 K (+36.83 %)
Mar 22 2018	KERX	KERYX BIOPHARMACEU ...	Carberry Christine A.	Chief Operating Off ...	Option Exercise	A	4.16	82,500	343,200	82,500
Mar 22 2018	KERX	KERYX BIOPHARMACEU ...	Carberry Christine A.	Chief Operating Off ...	Grant	A	0.00	41,250	0	117,202	76 K to 117.2 K (+54.31 %)
Mar 22 2018	KERX	KERYX BIOPHARMACEU ...	Holmes Scott A	Chief Financial Off ...	Option Exercise	A	4.16	82,500	343,200	82,500
Mar 22 2018	KERX	KERYX BIOPHARMACEU ...	Holmes Scott A	Chief Financial Off ...	Grant	A	0.00	41,250	0	172,469	131.2 K to 172.5 K (+31.44 %)
Mar 22 2018	KERX	KERYX BIOPHARMACEU ...	Neylan John F.	Chief Medical Offic ...	Option Exercise	A	4.16	82,500	343,200	82,500
Mar 22 2018	KERX	KERYX BIOPHARMACEU ...	Neylan John F.	Chief Medical Offic ...	Grant	A	0.00	41,250	0	156,736	115.5 K to 156.7 K (+35.72 %)
Feb 16 2018	KERX	KERYX BIOPHARMACEU ...	Adams Brian	General Counsel and ...	Sell	S	4.81	5,652	27,186	126,069	131.7 K to 126.1 K (-4.29 %)
Jan 31 2018	KERX	KERYX BIOPHARMACEU ...	Madison Greg	President and CEO	Grant	A	4.81	4,403	21,178	429,404	433.8 K to 429.4 K (-1.01 %)
Jan 31 2018	KERX	KERYX BIOPHARMACEU ...	Madison Greg	President and CEO	Payment of Exercise	F	5.15	58,813	302,887	433,807	492.6 K to 433.8 K (-11.94 %)
Jan 31 2018	KERX	KERYX BIOPHARMACEU ...	Madison Greg	President and CEO	Grant	A	0.00	125,000	0	492,620	367.6 K to 492.6 K (+34.00 %)
Jan 31 2018	KERX	KERYX BIOPHARMACEU ...	Holmes Scott A	Chief Financial Off ...	Sell	S	4.81	2,830	13,612	136,870	139.7 K to 136.9 K (-2.03 %)
Jan 31 2018	KERX	KERYX BIOPHARMACEU ...	Neylan John F.	Chief Medical Offic ...	Sell	S	4.81	1,541	7,412	121,138	122.7 K to 121.1 K (-1.26 %)
Jan 31 2018	KERX	KERYX BIOPHARMACEU ...	Adams Brian	General Counsel and ...	Sell	S	4.81	1,541	7,412	131,721	133.3 K to 131.7 K (-1.16 %)
Jan 24 2018	KERX	KERYX BIOPHARMACEU ...	Neylan John F.	Chief Medical Offic ...	Sell	S	4.92	1,322	6,504	122,679	124 K to 122.7 K (-1.07 %)
Jan 22 2018	KERX	KERYX BIOPHARMACEU ...	Carberry Christine A.	Chief Operating Off ...	Sell	S	4.87	9,048	44,064	75,952	85 K to 76 K (-10.64 %)
Jan 08 2018	KERX	KERYX BIOPHARMACEU ...	Adams Brian	General Counsel and ...	Sell	S	4.69	753	3,532	133,262	134 K to 133.3 K (-0.56 %)
Jan 08 2018	KERX	KERYX BIOPHARMACEU ...	Madison Greg	President and CEO	Sell	S	4.69	1,067	5,004	367,620	368.7 K to 367.6 K (-0.29 %)
Oct 31 2017	KERX	KERYX BIOPHARMACEU ...	Neylan John F.	Chief Medical Offic ...	Sell	S	6.03	1,405	8,472	124,001	125.4 K to 124 K (-1.12 %)
Oct 31 2017	KERX	KERYX BIOPHARMACEU ...	Holmes Scott A	Chief Financial Off ...	Sell	S	6.03	2,582	15,569	139,700	142.3 K to 139.7 K (-1.81 %)
Oct 31 2017	KERX	KERYX BIOPHARMACEU ...	Madison Greg	President and CEO	Sell	S	6.03	4,055	24,452	368,687	372.7 K to 368.7 K (-1.09 %)
Oct 31 2017	KERX	KERYX BIOPHARMACEU ...	Adams Brian	General Counsel and ...	Sell	S	6.03	1,405	8,472	134,015	135.4 K to 134 K (-1.04 %)
Oct 24 2017	KERX	KERYX BIOPHARMACEU ...	Neylan John F.	Chief Medical Offic ...	Sell	S	6.53	1,179	7,699	125,406	126.6 K to 125.4 K (-0.93 %)
Oct 06 2017	KERX	KERYX BIOPHARMACEU ...	Adams Brian	General Counsel and ...	Sell	S	7.19	630	4,530	135,420	136.1 K to 135.4 K (-0.46 %)
Oct 06 2017	KERX	KERYX BIOPHARMACEU ...	Madison Greg	President and CEO	Sell	S	7.19	895	6,435	372,742	373.6 K to 372.7 K (-0.24 %)
Sep 13 2017	KERX	KERYX BIOPHARMACEU ...	Enyedy Mark J	Director	Option Exercise	A	7.32	50,000	366,000	50,000
Aug 01 2017	KERX	KERYX BIOPHARMACEU ...	Madison Greg	President and CEO	Sell	S	7.14	4,131	29,495	373,637	377.8 K to 373.6 K (-1.09 %)
Aug 01 2017	KERX	KERYX BIOPHARMACEU ...	Adams Brian	General Counsel and ...	Sell	S	7.14	1,445	10,317	136,050	137.5 K to 136.1 K (-1.05 %)
Aug 01 2017	KERX	KERYX BIOPHARMACEU ...	Holmes Scott A	Chief Financial Off ...	Sell	S	7.14	1,445	10,317	142,282	143.7 K to 142.3 K (-1.01 %)
Aug 01 2017	KERX	KERYX BIOPHARMACEU ...	Neylan John F.	Chief Medical Offic ...	Sell	S	7.14	1,445	10,317	126,585	128 K to 126.6 K (-1.13 %)
Jul 31 2017	KERX	KERYX BIOPHARMACEU ...	Holmes Scott A	Chief Financial Off ...	Sell	S	6.96	1,236	8,603	143,727	145 K to 143.7 K (-0.85 %)
Jul 25 2017	KERX	KERYX BIOPHARMACEU ...	Neylan John F.	Chief Medical Offic ...	Sell	S	7.27	1,214	8,826	128,030	129.2 K to 128 K (-0.94 %)
Jul 06 2017	KERX	KERYX BIOPHARMACEU ...	Madison Greg	President and CEO	Sell	S	7.67	910	6,980	377,768	378.7 K to 377.8 K (-0.24 %)
Jul 06 2017	KERX	KERYX BIOPHARMACEU ...	Adams Brian	General Counsel and ...	Sell	S	7.67	641	4,916	137,495	138.1 K to 137.5 K (-0.46 %)
Jun 20 2017	KERX	KERYX BIOPHARMACEU ...	Cameron Kevin J	Director	Option Exercise	A	6.56	30,000	196,800	30,000
Jun 20 2017	KERX	KERYX BIOPHARMACEU ...	Cameron Kevin J	Director	Grant	A	0.00	10,000	0	170,000	160 K to 170 K (+6.25 %)
Jun 20 2017	KERX	KERYX BIOPHARMACEU ...	Heffernan Michael Thomas	Director	Option Exercise	A	6.56	30,000	196,800	30,000
Jun 20 2017	KERX	KERYX BIOPHARMACEU ...	Heffernan Michael Thomas	Director	Grant	A	0.00	10,000	0	10,000	0 to 10 K
Jun 20 2017	KERX	KERYX BIOPHARMACEU ...	Butler John P.	Director	Option Exercise	A	6.56	30,000	196,800	30,000
Jun 20 2017	KERX	KERYX BIOPHARMACEU ...	Butler John P.	Director	Grant	A	0.00	10,000	0	20,000	10 K to 20 K (+100.00 %)
Jun 20 2017	KERX	KERYX BIOPHARMACEU ...	Regan Daniel Paul	Director	Option Exercise	A	6.56	30,000	196,800	30,000
Jun 20 2017	KERX	KERYX BIOPHARMACEU ...	Regan Daniel Paul	Director	Grant	A	0.00	10,000	0	50,000	40 K to 50 K (+25.00 %)
Jun 20 2017	KERX	KERYX BIOPHARMACEU ...	ROGERS MICHAEL W	Director	Option Exercise	A	6.56	30,000	196,800	30,000
Jun 20 2017	KERX	KERYX BIOPHARMACEU ...	ROGERS MICHAEL W	Director	Grant	A	0.00	10,000	0	20,000	10 K to 20 K (+100.00 %)
Jun 20 2017	KERX	KERYX BIOPHARMACEU ...	Morrison Jodie Pope	Director	Option Exercise	A	6.56	30,000	196,800	30,000
Jun 20 2017	KERX	KERYX BIOPHARMACEU ...	Morrison Jodie Pope	Director	Grant	A	0.00	10,000	0	10,000	0 to 10 K
Jun 20 2017	KERX	KERYX BIOPHARMACEU ...	GILMAN STEVEN C	Director	Option Exercise	A	6.56	30,000	196,800	30,000
Jun 20 2017	KERX	KERYX BIOPHARMACEU ...	GILMAN STEVEN C	Director	Grant	A	0.00	10,000	0	20,000	10 K to 20 K (+100.00 %)
Apr 18 2017	KERX	KERYX BIOPHARMACEU ...	Adams Brian	General Counsel and ...	Sell	S	5.75	1,090	6,268	139,577	140.7 K to 139.6 K (-0.77 %)
Apr 06 2017	KERX	KERYX BIOPHARMACEU ...	Madison Greg	President and CEO	Sell	S	5.80	911	5,284	382,800	383.7 K to 382.8 K (-0.24 %)
Apr 06 2017	KERX	KERYX BIOPHARMACEU ...	Adams Brian	General Counsel and ...	Sell	S	5.80	642	3,724	140,667	141.3 K to 140.7 K (-0.45 %)
Mar 15 2017	KERX	KERYX BIOPHARMACEU ...	Neylan John F.	Chief Medical Offic ...	Option Exercise	A	5.53	97,500	539,175	97,500
Mar 15 2017	KERX	KERYX BIOPHARMACEU ...	Neylan John F.	Chief Medical Offic ...	Grant	A	0.00	48,750	0	131,894	83.1 K to 131.9 K (+58.63 %)
Mar 15 2017	KERX	KERYX BIOPHARMACEU ...	Adams Brian	General Counsel and ...	Option Exercise	A	5.53	97,500	539,175	97,500
Mar 15 2017	KERX	KERYX BIOPHARMACEU ...	Adams Brian	General Counsel and ...	Grant	A	0.00	48,750	0	141,309	92.6 K to 141.3 K (+52.67 %)
Mar 15 2017	KERX	KERYX BIOPHARMACEU ...	Madison Greg	President and CEO	Option Exercise	A	5.53	300,000	1,659,000	300,000
Mar 15 2017	KERX	KERYX BIOPHARMACEU ...	Madison Greg	President and CEO	Grant	A	0.00	150,000	0	383,711	233.7 K to 383.7 K (+64.18 %)
Mar 15 2017	KERX	KERYX BIOPHARMACEU ...	Holmes Scott A	Chief Financial Off ...	Option Exercise	A	5.53	97,500	539,175	97,500
Mar 15 2017	KERX	KERYX BIOPHARMACEU ...	Holmes Scott A	Chief Financial Off ...	Grant	A	0.00	48,750	0	147,623	98.9 K to 147.6 K (+49.31 %)
Feb 13 2017	KERX	KERYX BIOPHARMACEU ...	Madison Greg	President and CEO	Sell	S	5.47	1,611	8,812	233,711	235.3 K to 233.7 K (-0.68 %)
Jan 31 2017	KERX	KERYX BIOPHARMACEU ...	Adams Brian	General Counsel and ...	Sell	S	4.65	6,984	32,476	92,559	99.5 K to 92.6 K (-7.02 %)
Jan 31 2017	KERX	KERYX BIOPHARMACEU ...	Neylan John F.	Chief Medical Offic ...	Sell	S	4.65	6,984	32,476	83,144	90.1 K to 83.1 K (-7.75 %)
Jan 31 2017	KERX	KERYX BIOPHARMACEU ...	Holmes Scott A	Chief Financial Off ...	Sell	S	4.65	8,447	39,279	98,873	107.3 K to 98.9 K (-7.87 %)
Jan 31 2017	KERX	KERYX BIOPHARMACEU ...	Madison Greg	President and CEO	Sell	S	4.65	18,248	84,853	235,322	253.6 K to 235.3 K (-7.20 %)
Jan 25 2017	KERX	KERYX BIOPHARMACEU ...	Neylan John F.	Chief Medical Offic ...	Sell	S	5.39	1,428	7,697	90,128	91.6 K to 90.1 K (-1.56 %)
Jan 18 2017	KERX	KERYX BIOPHARMACEU ...	Carberry Christine A.	Chief Operating Off ...	Option Exercise	A	6.02	170,000	1,023,400	170,000
Jan 18 2017	KERX	KERYX BIOPHARMACEU ...	Carberry Christine A.	Chief Operating Off ...	Grant	A	0.00	85,000	0	85,000	0 to 85 K
Jan 18 2017	KERX	KERYX BIOPHARMACEU ...	Adams Brian	VP and General Coun ...	Sell	S	6.24	1,265	7,894	99,543	100.8 K to 99.5 K (-1.25 %)
Jan 06 2017	KERX	KERYX BIOPHARMACEU ...	Adams Brian	VP and General Coun ...	Sell	S	6.16	759	4,675	100,808	101.6 K to 100.8 K (-0.75 %)
Jan 06 2017	KERX	KERYX BIOPHARMACEU ...	Madison Greg	President and CEO	Sell	S	6.16	1,077	6,634	253,570	254.6 K to 253.6 K (-0.42 %)
Nov 14 2016	KERX	KERYX BIOPHARMACEU ...	Madison Greg	President and CEO	Sell	S	4.99	1,559	7,779	254,647	256.2 K to 254.6 K (-0.61 %)
Oct 31 2016	KERX	KERYX BIOPHARMACEU ...	Holmes Scott A	Chief Financial Off ...	Sell	S	4.44	1,237	5,492	107,320	108.6 K to 107.3 K (-1.14 %)
Oct 25 2016	KERX	KERYX BIOPHARMACEU ...	Neylan John F.	Chief Medical Offic ...	Sell	S	4.72	1,211	5,716	91,556	92.8 K to 91.6 K (-1.31 %)
Oct 18 2016	KERX	KERYX BIOPHARMACEU ...	Adams Brian	VP and General Coun ...	Sell	S	4.86	1,106	5,375	101,567	102.7 K to 101.6 K (-1.08 %)
Oct 06 2016	KERX	KERYX BIOPHARMACEU ...	Madison Greg	President and CEO	Sell	S	5.38	917	4,933	256,206	257.1 K to 256.2 K (-0.36 %)
Oct 06 2016	KERX	KERYX BIOPHARMACEU ...	Adams Brian	VP and General Coun ...	Sell	S	5.38	647	3,481	102,673	103.3 K to 102.7 K (-0.63 %)
Aug 11 2016	KERX	KERYX BIOPHARMACEU ...	Madison Greg	President and CEO	Sell	S	4.22	1,622	6,845	257,123	258.7 K to 257.1 K (-0.63 %)
Aug 11 2016	KERX	KERYX BIOPHARMACEU ...	Madison Greg	President and CEO	Sell	S	4.22	1,622	6,845	257,123	258.7 K to 257.1 K (-0.63 %)
Aug 02 2016	KERX	KERYX BIOPHARMACEU ...	Holmes Scott A	Chief Financial Off ...	Sell	S	7.36	4,935	36,322	108,557	113.5 K to 108.6 K (-4.35 %)
Jul 27 2016	KERX	KERYX BIOPHARMACEU ...	Neylan John F.	Chief Medical Offic ...	Sell	S	7.43	1,217	9,042	92,767	94 K to 92.8 K (-1.29 %)
Jul 18 2016	KERX	KERYX BIOPHARMACEU ...	Adams Brian	VP and General Coun ...	Sell	S	7.01	1,083	7,592	103,320	104.4 K to 103.3 K (-1.04 %)
Jul 06 2016	KERX	KERYX BIOPHARMACEU ...	Adams Brian	VP and General Coun ...	Sell	S	6.66	660	4,396	104,403	105.1 K to 104.4 K (-0.63 %)
Jul 06 2016	KERX	KERYX BIOPHARMACEU ...	Madison Greg	President and CEO	Sell	S	6.66	936	6,234	258,745	259.7 K to 258.7 K (-0.36 %)
Jun 23 2016	KERX	KERYX BIOPHARMACEU ...	Heffernan Michael Thomas	Director	Option Exercise	A	6.05	50,000	302,500	50,000
Jun 23 2016	KERX	KERYX BIOPHARMACEU ...	Morrison Jodie Pope	Director	Option Exercise	A	6.05	50,000	302,500	50,000

Page: 1 2 3 4 5 ... 5 next >